Sharad Adekar, Medical Chair Lead and Currien MacDonald, Medical Chair Director at WCG, discuss the risks and benefits of using immunotherapies to treat cancer.  In the last decade, a paradigm shift has occurred in the landscape of cancer treatment1. Supported by current advances in understanding of the mechanism and pathways regulating immune system activation and […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!